{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:53:55Z","timestamp":1776844435685,"version":"3.51.2"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ajogmf.2024.101571","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:16:44Z","timestamp":1732666604000},"page":"101571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S","title":["Vaginal progesterone for prevention of preterm birth in women with a history of preterm birth regardless of cervical length: an argument against use"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5539-5649","authenticated-orcid":false,"given":"Anthony Melendez","family":"Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarahn","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2024.101571_bib0001","first-page":"247","article-title":"WHO: recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976","volume":"56","year":"1977","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0002","series-title":"Leading health indicators for healthy people 2010: final report","year":"1999"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0003","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2018.04.003","article-title":"The global epidemiology of preterm birth","volume":"52","author":"Vogel","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0004","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.siny.2015.12.011","article-title":"The epidemiology, etiology, and costs of preterm birth","volume":"21","author":"Frey","year":"2016","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0005","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","article-title":"National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications","volume":"379","author":"Blencowe","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0006","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00404-019-05095-y","article-title":"Prevention of spontaneous preterm birth","volume":"299","author":"Daskalakis","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0007","first-page":"891","article-title":"4 million neonatal deaths: when? Where? Why? The Lancet","volume":"365","author":"Lawn","year":"2005","journal-title":"Where?"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0008","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(23)00878-4","article-title":"National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis","volume":"402","author":"Ohuma","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0009","unstructured":"2023 March of Dimes Report Card: The state of maternal and infant health for American families. Help Us Improve the Health of All Moms and Babies. Available at: www.marchofdimes.org\/report-card. Accessed April 15, 2024."},{"key":"10.1016\/j.ajogmf.2024.101571_bib0010","first-page":"1","article-title":"Shifts in the distribution of births by gestational age, United States, 2014\u20132022","volume":"73","author":"Martin","year":"2024","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2023.01.006","article-title":"Preterm birth and total health care use and costs in the first 5 years of life: a population-based study","volume":"258","author":"Yu","year":"2023","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0012","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.clp.2020.08.001","article-title":"Current preterm birth prevention strategies","volume":"47","author":"Breslin","year":"2020","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0013","unstructured":"Behrman RE, Butler AS, Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy Outcomes, eds. Preterm birth: causes, consequences, and prevention. Washington, DC: National Academies Press; 2007."},{"key":"10.1016\/j.ajogmf.2024.101571_bib0014","first-page":"1","article-title":"Births: final data for 2018","volume":"68","author":"Martin","year":"2019","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0015","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0016","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/AOG.0000000000004479","article-title":"Prediction and prevention of spontaneous preterm birth: ACOG Practice Bulletin, Number 234","volume":"138","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0017","doi-asserted-by":"crossref","first-page":"576.e1","DOI":"10.1016\/j.ajog.2007.01.039","article-title":"Recurrence risk for preterm delivery","volume":"196","author":"McManemy","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0018","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ajog.2011.10.864","article-title":"Challenges in defining and classifying the preterm birth syndrome","volume":"206","author":"Kramer","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0019","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1056\/NEJM199908263410906","article-title":"The control of labor","volume":"341","author":"Norwitz","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0020","first-page":"514","article-title":"Endocrine and paracrine regulation of birth at term and preterm","volume":"21","author":"Challis","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0021","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1073\/pnas.1633616100","article-title":"A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition","volume":"100","author":"Condon","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0022","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.ajog.2005.05.071","article-title":"Progesterone receptor isoform (A\/B) ratio of human fetal membranes increases during term parturition","volume":"193","author":"Oh","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0023","doi-asserted-by":"crossref","first-page":"20828","DOI":"10.1073\/pnas.1008301107","article-title":"miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor","volume":"107","author":"Renthal","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0024","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1933719110382922","article-title":"Progesterone receptors in the human pregnancy uterus: do they hold the key to birth timing?","volume":"18","author":"Mesiano","year":"2011","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0025","doi-asserted-by":"crossref","first-page":"391.e1","DOI":"10.1016\/j.ajog.2008.06.085","article-title":"Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions","volume":"199","author":"Ruddock","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0026","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ajog.2013.04.027","article-title":"Progesterone is not the same as 17a-hydroxyprogesterone caproate: implications for obstetrical practice","volume":"208","author":"Romero","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.08.010","article-title":"Vaginal progesterone, but not 17a-hydroxyprogesterone caproate, has anti-inflammatory effects at the murine maternal-fetal interface","volume":"213","author":"Furcron","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.06.014","article-title":"Progesterone inhibits in vitro fetal membrane weakening","volume":"213","author":"Kumar","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2023.101116","article-title":"Vaginal progesterone for the prevention of recurrent spontaneous preterm birth","volume":"5","author":"Berghella","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jri.2017.12.004","article-title":"Intrauterine inflammatory activation, functional progesterone withdrawal, and the timing of term and preterm birth","volume":"125","author":"Keelan","year":"2018","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0031","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.semperi.2017.07.013","article-title":"Pathophysiology of preterm labor with intact membranes","volume":"41","author":"Talati","year":"2017","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0032","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.placenta.2020.02.005","article-title":"Myometrial Activation: novel concepts underlying labor","volume":"92","author":"Shynlova","year":"2020","journal-title":"Placenta"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0033","doi-asserted-by":"crossref","first-page":"11565","DOI":"10.1038\/ncomms11565","article-title":"Molecular evidence of functional progesterone withdrawal in human myometrium","volume":"7","author":"Nadeem","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0034","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12916-016-0632-4","article-title":"Modeling hormonal and inflammatory contributions to preterm and term labor using uterine temporal transcriptomics","volume":"14","author":"Migale","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0035","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1111\/jcmm.16681","article-title":"Pro-Inflammatory signals induce 20\u0391-HSD expression in myometrial cells: a key mechanism for local progesterone withdrawal","volume":"25","author":"Nadeem","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0036","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s43032-022-01000-2","article-title":"Assessing the potency of the novel tocolytics 2-APB, glycyl-h-1152, and HC-067047 in pregnant human myometrium","volume":"30","author":"MdR","year":"2023","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0037","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3390\/biom13061005","article-title":"\u03923 receptor signaling in pregnant human myometrium suggests a role for \u03b23 agonists as tocolytics","volume":"13","author":"Buxton","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0038","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1038\/s41598-019-42181-2","article-title":"Oxytocin receptor antagonists, atosiban and Nolasiban, inhibit prostaglandin F2\u0391-induced contractions and inflammatory responses in human myometrium","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0039","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/1471-0528.13744","article-title":"Pharmacogenomics of preterm birth prevention and treatment","volume":"123","author":"Manuck","year":"2016","journal-title":"BJOG"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.semperi.2017.08.008","article-title":"Tocolysis: present and future treatment options","volume":"41","author":"Younger","year":"2017","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0041","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajog.2022.04.023","article-title":"Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? evidence from a systematic review and meta-analysis","volume":"227","author":"Conde-Agudelo","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0042","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"Da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0043","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/01443610902980878","article-title":"Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India","volume":"29","author":"Majhi","year":"2009","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0044","first-page":"11","article-title":"Evaluation of the effect of progesterone on prevention of preterm delivery and its complications","volume":"14","author":"Akbari","year":"2009","journal-title":"Sci J Kurdistan Univ Med Sci"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00404-009-1351-2","article-title":"Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial","volume":"283","author":"Cetingoz","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0046","first-page":"101","article-title":"Randomized trial of natural progesterone in prevention of preterm birth in high risk women","author":"Modi","year":"2014","journal-title":"J Pediatr Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0047","first-page":"309","article-title":"Vaginal progesterone on the prevention of preterm birth and neonatal complications in high risk women: a randomized placebo-controlled double-blind study","volume":"14","author":"Azargoon","year":"2016","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0048","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4236\/ojog.2018.84036","article-title":"Role of Vaginal Progesterone in Prevention of Preterm Labor in Women with Previous History of One or More Previous Preterm Births","volume":"08","author":"Abdou","year":"2018","journal-title":"Open J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0049","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.5158","article-title":"Progesterone vaginal gel for the reduction recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"O'Brien","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0050","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(16)00350-0","article-title":"Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial","volume":"387","author":"Norman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002390","article-title":"Vaginal progesterone pessaries for pregnant women with a previous preterm birth to prevent neonatal respiratory distress syndrome (the PROGRESS study): a multicentre, randomised, placebo-controlled trial","volume":"14","author":"Crowther","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100658","article-title":"Vaginal progesterone compared with intramuscular 17-alpha-hydroxyprogesterone caproate for prevention of recurrent preterm birth in Singleton gestations: a systematic review and meta-analysis","volume":"4","author":"Boelig","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0053","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajog.2018.03.028","article-title":"Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis","volume":"219","author":"Conde-Agudelo","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2011.12.003","article-title":"Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and meta analysis of individual patient data","volume":"206","author":"Romero","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0055","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/uog.15953","article-title":"Vaginal progesterone decreases preterm birth \u226434weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study","volume":"48","author":"Romero","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0056","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajog.2017.11.576","article-title":"Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data","volume":"218","author":"Romero","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0057","unstructured":"ACOG statement on the FDA withdrawal of 17-OHPC. American College of Obstetricians and Gynecologists. 2023. Available at:https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2023\/04\/updated-guidance-use-of-progesterone-supplementation-for-prevention-of-recurrent-preterm-birth. Accessed April 19, 2024."},{"key":"10.1016\/j.ajogmf.2024.101571_bib0058","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2023.04.012","article-title":"Society for Maternal-Fetal Medicine Statement: response to the Food and Drug Administration's withdrawal of 17-alpha hydroxyprogesterone caproate","volume":"229","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0059","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1001\/jamainternmed.2023.8433","article-title":"Racial differences in shared decision-making about critical illness","volume":"184","author":"Ashana","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr088","article-title":"Thalidomide: the tragedy of birth defects and the effective treatment of disease [published correction appears in Toxicol Sci 2012;125:613]","volume":"122","author":"Kim","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.ajogmf.2024.101571_bib0061","article-title":"Preterm birth drug withdrawn after 12 years","author":"Jewett","year":"2023","journal-title":"The New York Times"}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933324002970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933324002970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T12:06:53Z","timestamp":1744978013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933324002970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2589933324002970"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2024.101571","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaginal progesterone for prevention of preterm birth in women with a history of preterm birth regardless of cervical length: an argument against use","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2024.101571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101571"}}